Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 27 Article 3
Back to Table of Contents

Eurosurveillance, Volume 7, Issue 27, 03 July 2003

Citation style for this article: Editorial team. Source of US monkeypox outbreak of identified, and CDC issues updated interim guidance for prevention and treatment of monkeypox. Euro Surveill. 2003;7(27):pii=2251. Available online:

Source of US monkeypox outbreak of identified, and CDC issues updated interim guidance for prevention and treatment of monkeypox

Editorial team (, Eurosurveillance editorial office.

The Centers for Disease Control and Prevention (CDC) in the United States (US) believes it has identified the source of the current outbreak of monkeypox, after confirming the presence of monkeypox virus in one Gambian giant rat, three dormice, and two rope squirrels that were part of a shipment of African rodents imported into the US on 9 April. (1)

As of 1 July, 81 cases of human monkeypox had been reported to CDC (2). CDC and local US state health departments continue to investigate cases among persons who had contact with pet prairie dogs or other small mammals (3). Thirty two (40%) of the 81 cases have been laboratory confirmed for monkeypox (2).

The reported cases are widely dispersed over the midwestern states. So far there have been reports from Illinois (16), Indiana (22), Kansas (one), Missouri (two), Ohio (one), and Wisconsin (39). No cases of monkeypox that could be attributed exclusively to person to person contact have been confirmed (3).

CDC has issued updated interim guidance on the use of smallpox vaccine, cidofovir, and vaccinia immunoglobulin for prevention and treatment in the setting of an outbreak of monkeypox, and an updated case definition for human cases of monkeypox (4,5). CDC has also issued interim guidance calling for the euthanasia of animals that were imported from Ghana on 9 April, or that have been exposed to other animals infected with monkeypox (6). Up to date information on the outbreak is available at

  1. CDC. CDC Confirms monkeypox in rodents. Interim recommendations aim to curb further spread. Press release, 2 July 2003. ( [accessed 3 July 2003]
  2. CDC. Monkeypox report of cases in the United States case count, 1 July 2003. 2 July 2003. ( [accessed 3 July 2003]
  3. CDC. Update: multistate outbreak of Monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 589-90. (
  4. CDC. Interim guidance for use of smallpox vaccine, cidofovir, and VIG for prevention and treatment in the setting of an outbreak of monkeypox infections. 2 July 2003. ( [accessed 3 July 2003]
  5. CDC. Updated interim case definition for human case of monkeypox. 2 July 2003. ( [accessed 3 July 2003]
  6. CDC. Interim guidance to state and local governments for the removal of state- and locally imposed quarantine orders and the euthanasia of animals affected by the monkeypox outbreak. 1 July 2003. ( [accessed 3 July 2003]

back to top

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.